Updated from 3:01 p.m.
( ADLR) were among the best-performing health-related stocks Tuesday, rising 16.2% after the company and its partner
announced that their Entereg drug showed positive results in a phase II study.
The drug is used by patients who suffer from bowel dysfunction caused by the extended use of drugs aimed to help sufferers of chronic pain. The drug helped increase the frequency of bowel movements, and showed better straining and stool consistency when compared with a placebo. "We are delighted that the results of this study suggest that patients taking opioids such as morphine or codeine may benefit from use on Entereg and believe that the convenience of oral dosing is optimal for development in this patient population," Adolor said. Shares traded up $1.43 to $10.25.
( BNT) fell 7% after the company posted better-than-expected fourth-quarter earnings on sales that fell short of expectations. The drug delivery company posted earnings of $1.98 million, or 9 cents a share, on sales of $19.5 million. Analysts surveyed by Thomson First Call were expecting earnings of 8 cents a share on sales of $23 million. A year ago the company earned $1.7 million, or 8 cents a share, on sales of $18.1 million. Shares traded down 68 cents to $9.05.
fell 3.3% after the provider of diagnostic imaging services posted fourth-quarter earnings that matched expectations. Excluding items, the company earned 9 cents a share on sales of $107.2 million. Analysts were expecting earnings of 9 cents a share. A year ago the company earned 10 cents a share on sales of $101.6 million. For all of 2004, the company earned 49 cents a share, down from 56 cents a year ago, on sales of $432.1 million, which was up from last year's $415.3 million. Shares traded down 38 cents to $11.33.
, a supplier of components used in implantable medical devices, fell 1.3% after the company said it plans to close its Carson City, Nev., facility and consolidate the work being done at the Carson City facility into a facility in Tijuana, Mexico. The cost for the consolidation is expected to be between $4.5 million and $5.4 million, or 15 cents to 18 cents a share. The company expects to absorb the costs over the next four quarters. Structural cost savings, meanwhile, are expected to range from $2.5 million to $3.1 million beginning in the second quarter of 2006. As a result of the facility consolidation, the company now expects to post 2005 earnings of 7 cents to 15 cents a share, down from previous guidance of 25 cents to 30 cents a share. Shares traded down 22 cents to $17.35.
Other health care movers included
, up 69 cents to $7.13;
, down 42 cents to $26.76;
, up 76 cents to $38.35;
( MLNM), down 28 cents to $8.06;
, down 96 cents to $29.77;
, up 3 cents to $31.73;
Johnson & Johnson
, down 25 cents to $68.19;
, up 60 cents to $54.60; and
, down 36 cents to $61.75.